Candel Therapeutics, Inc.
NASDAQ:CADL
4.65 (USD) • At close November 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 35.413 | 70.058 | 82.642 | 35.053 | 5.179 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 39.878 |
| Cash and Short Term Investments
| 35.413 | 70.058 | 82.642 | 35.053 | 45.057 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.384 | 1.887 | 2.303 | 0.093 | 0.153 |
| Total Current Assets
| 36.797 | 71.945 | 84.945 | 35.146 | 45.21 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 4.022 | 5.48 | 3.836 | 2.787 | 0.425 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | -1.094 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.266 | 0.424 | 0.266 | 0.266 |
| Tax Assets
| 0 | 0.828 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.382 | 0.266 | 0 | 0.083 | 0 |
| Total Non-Current Assets
| 4.404 | 5.746 | 4.26 | 3.136 | 0.691 |
| Total Assets
| 41.201 | 77.691 | 89.205 | 38.282 | 45.901 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 0.422 | 0.38 | 1.59 | 0.921 | 0.218 |
| Short Term Debt
| 9.406 | 0.464 | 0 | 0.463 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.144 | 0 | 3.142 | 0 |
| Other Current Liabilities
| 3.934 | 4.247 | 2.182 | -0.734 | 0.974 |
| Total Current Liabilities
| 14.184 | 5.615 | 5.362 | 4.713 | 1.41 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 12.383 | 22.336 | 0.56 | 0.483 | 0.42 |
| Deferred Revenue Non-Current
| 0.973 | 0.144 | 0 | 0.125 | 0.25 |
| Deferred Tax Liabilities Non-Current
| 0.501 | 0.828 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.415 | 1.054 | 19.146 | 56.523 | 51.859 |
| Total Non-Current Liabilities
| 14.272 | 24.362 | 19.706 | 57.131 | 52.529 |
| Total Liabilities
| 28.456 | 29.977 | 25.068 | 61.844 | 53.939 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 89.205 | 49.06 | 49.06 |
| Common Stock
| 0.29 | 0.29 | 0.286 | 0.116 | 0.116 |
| Retained Earnings
| -137.028 | -99.089 | -80.295 | -44.171 | -26.491 |
| Accumulated Other Comprehensive Income/Loss
| -0 | -0 | -89.205 | -49.06 | -0.019 |
| Other Total Stockholders Equity
| 149.483 | -0.29 | 144.146 | 20.493 | -30.704 |
| Total Shareholders Equity
| 12.745 | -99.089 | 64.137 | -23.562 | -8.038 |
| Total Equity
| 12.745 | -99.089 | 64.137 | -23.562 | -8.038 |
| Total Liabilities & Shareholders Equity
| 41.201 | -69.112 | 89.205 | 38.282 | 45.901 |